Your account is not claimed yet. You can sign up with ORCID to claim your account.

And Craig R Lee (Craig R Lee)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Pharmacotherapy

Clinical pharmacology and therapeutics

Pharmacogenomics

The pharmacogenomics journal

This page only lists publications with an associated author ORCID identifier.

Publications

Cameron D Thomas, Alexis K Williams, And Craig R Lee, Larisa H Cavallari
Pharmacogenetics of P2Y 12 receptor inhibitors. Pharmacotherapy (2023)
Cameron D Thomas, Alexis K Williams, And Craig R Lee, Larisa H Cavallari
Pharmacogenetics of P2Y 12 Receptor Inhibitors. Pharmacotherapy (2023)
Cameron D Thomas, Alexis K Williams, And Craig R Lee, Larisa H Cavallari
Pharmacogenetics of P2Y 12 receptor inhibitors. Pharmacotherapy 43 (2) (2023)
Cameron D Thomas, Alexis K Williams, And Craig R Lee, Larisa H Cavallari
Pharmacogenetics of P2Y 12 receptor inhibitors. Pharmacotherapy 43 (2) (2023)
Cameron D Thomas, Alexis K Williams, And Craig R Lee, Larisa H Cavallari
Pharmacogenetics of P2Y 12 receptor inhibitors. Pharmacotherapy 43 (2) (2023)
Cameron D Thomas, Alexis K Williams, And Craig R Lee, Larisa H Cavallari
Pharmacogenetics of P2Y 12 receptor inhibitors. Pharmacotherapy (2023)
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, James C Lee, Julio D Duarte, Francesco Franchi, Sony Tuteja, Jay Giri, Philip E Empey, Rolf P Kreutz, Todd C Skaar, John M Allen, James C Coons, Yan Gong, Caitrin W McDonough, James M Stevenson, Cameron D Thomas, Julie A Johnson, George A Stouffer, Dominick J Angiolillo, And Craig R Lee, null null
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y 12 Inhibitor Prescribing After Percutaneous Coronary Intervention. Clinical pharmacology and therapeutics (2022)
Jacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, And Craig R Lee, Andrea N Edginton, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity. Clinical pharmacology and therapeutics 112 (2) (2022)
Ian R Mulrenin, Julian E Garcia, Muluneh M Fashe, Matthew Shane Loop, Melissa A Daubert, Rachel Peragallo Urrutia, And Craig R Lee
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions. Expert opinion on drug metabolism & toxicology 17 (11) (2022)
Lindsay Ratner, Jing 'Daisy' Zhu, Megan N Gower, Tejendra Patel, Jordan A Miller, Amber Cipriani, George A Stouffer, Daniel J Crona, And Craig R Lee
Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patients. Pharmacogenomics 23 (3) (2022)
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, George A Stouffer, Dominick J Angiolillo, Francesco Franchi, Sony Tuteja, Nita A Limdi, James C Lee, Julio D Duarte, Rolf P Kreutz, Todd C Skaar, James C Coons, Jay Giri, Caitrin W McDonough, Rachel Rowland, James M Stevenson, Thuy Nhu Thai, Mark R Vesely, Jacob T Wellen, Julie A Johnson, Almut G Winterstein, Larisa H Cavallari, And Craig R Lee, null null
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. Journal of the American Heart Association 11 (4) (2022)
Brian Wood, And Craig R Lee, Ian R Mulrenin, Megan N Gower, Joseph S Rossi, Karen E Weck, George A Stouffer
Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention. Pharmacotherapy (2021)
Megan N Gower, Lindsay R Ratner, Alexis K Williams, Joseph S Rossi, George A Stouffer, And Craig R Lee
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence. Pharmacogenomics and personalized medicine 13 (2020)
Rachel M Black, Alexis K Williams, Lindsay Ratner, Daniel J Crona, Tim Wiltshire, Karen E Weck, George A Stouffer, And Craig R Lee
Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients. Pharmacogenomics 21 (7) (2020)
Nita A Limdi, Larisa H Cavallari, And Craig R Lee, William B Hillegass, Ann M Holmes, Todd C Skaar, Maria Pisu, Chrisly Dillon, Amber L Beitelshees, Philip E Empey, Julio D Duarte, Vakaramoko Diaby, Yan Gong, Julie A Johnson, John Graves, Shawn Garbett, Zilu Zhou, Josh F Peterson, null null
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. The pharmacogenomics journal 20 (5) (2020)
Jesse Martin, Alexis K Williams, Melissa D Klein, Vindhya B Sriramoju, Shivanshu Madan, Joseph S Rossi, Megan Clarke, Jonathan D Cicci, Larisa H Cavallari, Karen E Weck, George A Stouffer, And Craig R Lee
Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting. Genetics in medicine : official journal of the American College of Medical Genetics 22 (1) (2019)

And Craig R Lee.css-eqlu8i{font-size:small;padding-left:4px;} (Craig R Lee)

Publication Activity (10 Years)

Top Topics

Top Venues

And Craig R Lee (Craig R Lee)